Alpha Cognition ACOG 深 沪
等待开盘 09-08 09:30:00 美东时间
9.52
+0.310
+3.37%
华盛通- 最 高9.54
- 今 开9.22
- 成交量 4.59万股
- 最 低 9.098
- 昨 收 9.21
- 总市值 2.07亿
- 52周最高 10.14
- 市盈率 静 --
- 换手率 0.21%
- 52周最低 4.50
- 委 比 13.04%
- 总股本 2177.79万
- 历史最高 11.54
- 量 比 0.34
- 振 幅 4.80%
- 历史最低 3.75
- 每 手 1
- 风险率 1.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Alpha Cognition Earnings Call: ZUNVEYL Drives Momentum
Alpha Cognition Inc (($ACOG)) has held its Q2 earnings call. Read on for the ma...
08-23 08:22
美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
08-21 11:40
美股大行评级 | 潜在涨幅455.56%！Cardiol Therapeutics获Canaccord Genuity上调目标价至10美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Cardiol Therapeutics"买入"评级，目标价从8美元升至10美元；B. Riley证券：维持Macrogenics"买入"评级，目标价从9美元升至11美元
08-18 11:39
HC Wainwright & Co. Maintains Buy on Alpha Cognition, Raises Price Target to $20
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Alpha Cognition (NASDAQ:ACOG) with a Buy and raises the price target from $18 to $20.
08-18 00:22
Alpha Cognition Q2 EPS $(0.40) Misses $(0.39) Estimate, Sales $6.092M Beat $4.384M Estimate
Alpha Cognition (NASDAQ:ACOG) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.39) by 2.56 percent. This is a 38.46 percent increase over losses of $(0.65) per share from the same period last year. The company reported quarterly sales of $6.092 millio...
08-14 04:09
Alpha Cognition’s RESOLVE Study: Fresh Real‑World Data on Zunveyl in Alzheimer’s Care
Alpha Cognition Inc ($ACOG) announced an update on their ongoing clinical study...
07-21 00:30
美股大行评级 | 潜在涨幅98.68%！DA Davidson上调Almonty Industries目标价至33美元，维持"买入"评级
今日重点评级关注：DA Davidson：维持Almonty Industries"买入"评级，目标价从25美元升至33美元；Stifel：维持Nurix Therapeutics"买入"评级，目标价从34美元升至40美元
07-13 10:13
Raymond James Initiates Coverage On Alpha Cognition with Outperform Rating, Announces Price Target of $20
Raymond James analyst Ryan Deschner initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Outperform rating and announces Price Target of $20.
07-10 18:53
Alpha Cognition Appoints Robert Wills As Board Chairman, Succeeding Len Mertz
Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeedin...
06-23 20:35
